These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23359520)

  • 1. Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome.
    Belcaro G; Cornelli U; Luzzi R; Cesarone MR; Dugall M; Feragalli B; Errichi S; Ippolito E; Grossi MG; Hosoi M; Cornelli M; Gizzi G
    Phytother Res; 2013 Oct; 27(10):1572-8. PubMed ID: 23359520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.
    Stefansson VTN; Schei J; Solbu MD; Jenssen TG; Melsom T; Eriksen BO
    Kidney Int; 2018 May; 93(5):1183-1190. PubMed ID: 29395334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pycnogenol® in Metabolic Syndrome and Related Disorders.
    Gulati OP
    Phytother Res; 2015 Jul; 29(7):949-68. PubMed ID: 25931421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
    Luzzi R; Belcaro G; Hosoi M; Feragalli B; Cornelli U; Dugall M; Ledda A
    Minerva Ginecol; 2017 Feb; 69(1):29-34. PubMed ID: 28116886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients.
    Papavasileiou MV; Karamanou AG; Kalogeropoulos P; Moustakas G; Patsianis S; Pittaras A
    J Hum Hypertens; 2016 Jul; 30(7):414-7. PubMed ID: 26134624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Metabolic Syndrome and Its Components in Patients with Carpal Tunnel Syndrome.
    Iftikhar S; Javed MA; Kasuri MN
    J Coll Physicians Surg Pak; 2016 May; 26(5):380-3. PubMed ID: 27225142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
    Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
    J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition.
    Errichi S; Bottari A; Belcaro G; Cesarone MR; Hosoi M; Cornelli U; Dugall M; Ledda A; Feragalli B
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):65-70. PubMed ID: 22108479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
    Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
    Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients.
    Ortega-Cortes R; Trujillo X; Hurtado López EF; López Beltrán AL; Colunga Rodríguez C; Barrera-de Leon JC; Tlacuilo-Parra A
    Arch Med Res; 2016 Jan; 47(1):40-8. PubMed ID: 26820798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.
    Vinciguerra G; Belcaro G; Bonanni E; Cesarone MR; Rotondi V; Ledda A; Hosoi M; Dugall M; Cacchio M; Cornelli U
    J Sports Med Phys Fitness; 2013 Dec; 53(6):644-54. PubMed ID: 24247188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and its components in men.
    Adriansjah H; Adam JM
    Acta Med Indones; 2005; 37(2):66-70. PubMed ID: 20066787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on interdependence and hierarchy of cardiovascular risk factors in hypertensive patients.
    Vyssoulis G; Karpanou E; Adamopoulos D; Tzamou V; Stefanadis C; Vischer UM
    Am J Cardiol; 2011 Jul; 108(2):240-5. PubMed ID: 21571245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
    Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
    Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Associations between metabolic syndrome and reduced lung function in young people].
    Kovalkova NA; Ragino YI; Travnikova NY; Denisova DV; Shcherbakova LV; Voevoda MI
    Ter Arkh; 2017; 89(10):54-61. PubMed ID: 29171471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Change in the prevalence of obesity phenotypes and cardiometabolic disorders among children aged 6- 17 in Beijing during 2004- 2013].
    Yan Y; Cheng H; Zhao X; Liu J; Hou D; Su Z; Huang G; Ding W; Liu Q; Mi J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jan; 50(1):34-9. PubMed ID: 26792501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.